December 9, 2011 โ Maquet announced Thursday it has restructured its U.S. Sales and Services Unit to meet the broader needs of customers across all areas of clinical care. As part of this restructuring, the company now offers a comprehensive disease therapy team dedicated to servicing customers who are building a hybrid operating room (OR).
December 9, 2011 โ Abbott announced Thursday the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial evaluating the safety, efficacy and performance of the Absorb bioresorbable vascular scaffold (BVS). The Absorb BVS will be compared to the company's Xience Prime everolimus-eluting coronary stent system.
December 9, 2011 โ The American Society of Echocardiography (ASE) and the Society of Cardiovascular Anesthesiologists (SCA) have released a new performance guideline for heightening the use of ultrasound in guided vascular cannulation. The process involves the insertion of a catheter, or tube, into a major vein or artery. The guideline also contains recommendations on training for these life-saving procedures.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 8, 2011 โ Two new studies report that echocardiography has a central role to play in identifying patients at risk of suffering heart damage from cancer therapies. They also report the procedure can be used in evaluating potential cardio protective treatments. Both studies were presented at EUROECHO 2011, held Dec. 7-10 in Budapest, Hungary.
December 8, 2011 โ Speckle training echocardiography (STE) is the subject of two studies being presented at EUROECHO 2011, Dec. 7-10 in Budapest, Hungary. They compare STE, a recent echocardiography technique, with magnetic resonance imaging (MRI) in quantifying infarct size (IS) after ST-elevation myocardial infarction (STEMI). MRI is the current gold standard for IS quantification.
December 8, 2011 โ A new survey released by the Siemens Radiation Reduction Alliance (SIERRA) reveals awareness and familiarity with medical imaging tests lead to clearer decisions for United States adults about their healthcare. The survey โ released at RSNA 2011 โ was conducted in response to increased scrutiny over medical imaging scans and the use of radiation.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 7, 2011 โ At RSNA 2011, Siemens Healthcare is unveiling the Somatom Perspective. It is the first computed tomography (CT) scanner to offer the eMode software solution, which helps determine the best correlation between dose, efficiency and image quality; it can also adjust the required scan parameters automatically.
The Miracor Picso Impulse system is supposed to prevent reperfusion injury and the no-flow phenomenon following ...
After spending a week walking the show floor and meeting with scores of vendors at the Radiological Society of North America (RSNA) 2011 annual meeting, the following are my choices for the most innovative new technologies presented.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 6, 2011 โ Heart Imaging Technologies (Heart IT), which pioneered the first U.S. Food and Drug Administration (FDA)-approved zero-footprint medical imaging workstation, and Johns Hopkins Medicine, announced the award of a National Institutes of Health (NIH) grant to enable the inclusion of medical images in the Nationwide Health Information Network (NHIN). The NHIN is a federal initiative of the National Office of the Coordinator for Health Information Technology.
December 6, 2011 โ Findings on coronary CT angiography (CTA), a noninvasive test to assess the coronary arteries for blockages, show different risk scenarios for men and women, according to a study presented today at the Radiological Society of North America (RSNA).
December 6, 2011 โ Kaleida Health, part of the Buffalo Heart Group in Buffalo, N.Y., announced its first implant of the AngelMed Guardian cardiac monitor and alert system Nov. 29. The system is designed to reduce the time it takes patients to get to the emergency room during an impending heart attack. Hashmat Ashraf, M.D., performed the first implant in the state of New York, and is among the first physicians across the United States to implant the experimental device.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 6, 2011 โ Boston Scientific Corp. announced U.S. Food and Drug Administration (FDA) approval of its Incepta, Energen and Punctua cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs). The devices are indicated to treat heart failure and sudden cardiac death.
December 6, 2011 โ W. L. Gore & Associates, Inc. (Gore) has received U.S. Food and Drug Administration (FDA) approval for new diameter sizes of the contralateral leg component of its Excluder AAA Endoprosthesis.
December 5, 2011 โ Roche announced that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a leading company in platelet function testing, the fastest-growing field in the coagulation diagnostics market.